ALCAT1 catalyzes CL pathological remodeling, which leads to ROS generation, mitochondrial dysfunction, and insulin resistance under the pathological conditions of diabetes, obesity, and cardiomyopathy [16, 18, 19]. Here, LCLAT1 is linked to obesity disorder.